Exciting developments in the field of oligonucleotide drugs
Jonathan Hall shares his perspective on the history of oligonucleotide drugs, collaborations with industry, Knowledge & Technology…
Stop does not always mean stop
The genetic code is believed to be strongly conserved through evolution – from the earliest bacteria until today. Now Estienne Swart et al. from the group of Mariusz…
"A protein as a “lock keeper
ETH researchers around Markus Stoffel have discovered that vigilin, a RNA-binding protein in liver cells, controls the synthesis and release of proteins that regulate…
A great opportunity to build international connections
The NCCR RNA & Disease offers mobility grants to PhD students and postdocs allowing the opportunity to conduct research in a laboratory…
"The field has kept on providing surprises and interesting things that nobody ever believed possible."
Daniel Schümperli looks back on 40 years of RNA biology and gives insights into his career as a…
Major role for minor spliceosome
Dysregulation of RNA metabolism is associated with a wide range of diseases, notably cancer and several neurological disorders. A deeper understanding of how…
Expanding the genome editing toolkit
In recent years, life science research has been transformed by the emergence of genome editing technologies based on the CRIS- PR-Cas system. Cas9 is a…
New support schemes for young scientists with family care duties
Female academics are a minority because at each branch point in the academic career a higher proportion of woman than man leaves…
Where NCCR scientists inspire each other
At the first annual RNA & Disease Retreat in Kandersteg NCCR scientists reported on their progress made in RNA research.
From January 19 to 21, more…
The deeper we dig, the more surprises we find
Professor Robert J. Schneider, the newest member of the NCCRs’ Scientific Advisory Board, shares his view on the NCCR RNA & Disease, the role of RNA…